Related content

Stem cell maintenance and disease progression in chronic myeloid leukemia

By Ito Takahiro  

International Journal of Hematology, Vol. 98, Iss. 6, 2013-12 ,pp. : 641-647

Springer Publishing Company

Access to resources Recommend Favorite

Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling—evaluation of risks and benefits

By Koh L.  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 286-294

Springer Publishing Company

Access to resources Recommend Favorite

Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis - A sequential study in 42 patients

By Hernandez-Boluda J.-C.   Cervantes F.   Colomer D.   Vela M.-C.   Costa D.   Paz M.-F.   Esteller M.   Montserrat E.  

Experimental Hematology, Vol. 31, Iss. 3, 2003-03 ,pp. : 204-210

Elsevier

Access to resources Recommend Favorite

Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions

By Ruiz J.C.   Campistol J.M.   Mota A.   Prats D.   Gutierrez J.A.   Castro A.   Garcia J.   Morales J.M.   Grynio J.M.   Gomez J.M.   Arias M.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1669-1670

Elsevier

Access to resources Recommend Favorite

Imatinib and beyond—the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia

By Berger U.  

Annals of Hematology, Vol. 83, Iss. 4, 2004-04 ,pp. : 258-264

Springer Publishing Company

Access to resources Recommend Favorite